Suven Life Sciences had announced the grant of five patents in various countries. These patents include the class of selective 5 HT (Hydroxytryptamine) compounds relating to the treatment of cognitive impairment leading to neurodegenerative diseases

Suven Life Sciences Ltd. from Hyderabad had announced the grant of one product patent from Mexico (No: 325948 and Title: Bicyclic compounds as ligands of the nicotinic receptor beta 2 acetylcholine alpha 4) and one product patent from Singapore (No: 180674 and Title: Bicyclic compounds as alpha-4-beta-2 nicotinic acetylcholine receptor ligands) that cover New Chemical...